A Cabozantinib Your Mates Is Preaching About

DNA from the CRC cell line http://www.selleckchem.com/products/z-vad-fmk.html HT-29 was used as a standard to control for the efficacy of the restriction enzymes, and double deionized water was used as a negative control. Exons 4 through 9 of the p53 gene were amplified using the primer sequences and PCR conditions of Bhatia et al,29 and a single-strand conformation polymorphism technique was used for all amplified PCR products as described by Fujita et al30(Table 2). Next, the samples that were identified as mutated by screening for p53 and K-ras were sequenced by using an automated sequencer (ABI PRISM 310; Applied Biosystems, Foster City, Calif) and were analyzed with sequencing analysis software programs. SPSS software (version 12-0; SPSS Inc., Chicago, Ill) was used for data analysis. Mean and standard deviations were used to describe quantitative data, and percentages http://www.selleckchem.com/products/ly2157299.html were used to describe qualitative data. Chi-square and Fisher exact tests were used to compare independent proportions. Kaplan-Meier survival estimates and log-rank tests were used to compare curves. Cox regression analysis was used for OS as the outcome (dependent variable), and different prognostic factors, including the tested markers, were used to depict independent effects on survival. Odds ratios were used to describe the likelihood of death or disease recurrence for 1 patient subgroup compared with another patient subgroup. P values http://www.selleck.cn/products/XL184.html Forty-four mutational events in p53 were detected in 29 patients (32.2%), including silent mutations, missense mutations, and frame-shift mutations, some of which have not been reported previously in patients with CRC (Table 3). Twenty patients (68.96%) had mutations in a single exon, and 9 patients (31.03%) had mutations in multiple exons. Exons 4 and 5 had the highest frequency of mutations (12 mutations each) followed by exon 8 (9 mutations), exon 7 (8 mutations), and exon 6 (3 mutations). No mutations were detected in exon 9. Three mutational hotspots were detected in exons, including 4 hotspots in codon 72 (12 patients), 7 hotspots in codon 245 (7 patients), and 8 hotspots in codon 273 (5 patients). To our knowledge, the 1 hotspot in exon 4 has not been reported previously in CRC. The most common types of mutations were transversions (50%) and transitions (45.5%). Overexpression of p53 was detected in 47 patients (52.2%), and 24 of those patients (51.1%) had mutations (Table 3, Fig. 1). The concordance between both techniques was 85.8% (P